The renal toxicity of harman and norharman, administered for 2 or 4 weeks at dietary levels of 1,000, 500, or 0 parts per million (ppm), was investigated in 6-week-old male F344/DuCj rats. Although rats fed 1,000 ppm harman or norharman, but not the 500 ppm level, demonstrated marked body weight retardation from 1 week to termination, no mortalities occurred. Marked elevation of water consumption was evident in rats given harman or norharman at 1,000 ppm, but not at 500 ppm, together with large increases in urine of low specific gravity. Urinary lysosomal enzymes (N-acetyl-B-D-glucosaminidase, NAG, and lactate dehydrogenase, LDH) and sugar levels were increased, and the brush border enzymes (7-glutamyl transpeptidase, GGT, and alkaline phosphatase, ALP) decreased. Furthermore, serum biochemistry revealed clear elevation of parameters indicating renal toxicity in these rats. Histopathologically, rats fed 1,000 ppm harman or norharman, but not 500 ppm, demonstrated focal toxic renal degenerativehecrotic and regenerative lesions in proximal, distal, and collecting tubules. These changes were associated with a clearly increased labeling index (LI) of the nuclei of renal tubular epithelial cells on immunohistochemical staining for 5-bromo-2'deoxyuridine (BrdU). Chemical specific crystal formation within tubular lumina was evident in rats fed 1,000 ppm, but not 500 ppm, this being considered the cause of the renal tubular lesions. It was concluded that harman and norharman exert renal toxicity at the dietary level of 1,000 ppm, but not 500 ppm, in male F344 rats. ' Keywords. Harman; norharman; renal toxicity; F344 rats 24, 25). Moreover, no carcinogenicity was evident
INTRODUCTION .
The aim of the present investigation was to clarify the renal toxicity of harman and norharman and Harman and norharman are parboline derivatives that have been found in tryptophan pyrolysate, to firm its dose dependencetobacco smoke, some edible plants, and charred meats (1 9, 2 1-23). The potential comutagenic activity of both chemicals when treated with polycyclic aromatic hydrocarbons has been extensively investigated with regard to possible human hazard in environmental carcinogenesis. However, the results of many in vitro studies concerning comutagenicity have been considered equivocal (1 0, 1 1 , 13, 1 5-1 7 TOXICOLOGIC PATHOLOGY itive air pressure was maintained with more than 15 air changeslhr.
Experinieiital Procedure
Animals were randomized into 5 groups of 10 rats each with equal group mean body weights. The rats were administered powdered diet (Oriental M y Oriental Yeast Co., Tokyo, Japan) containing harman or norharman at 1,000 or 500 ppm for up to 4 weeks, whereas control animals were maintained on basal diet. These doses were selected based on previous study results (3,6, 14) . Individual body weights were recorded weekly. Values for food and water consumption were measured over the 2-day period before each weighing. At 1, 3, 5 , 7, 14, and 28 days, 5 rats from each group were placed in urine-collecting cages without food and water, and 4-hr (from 9:OO A.M. to 1:00 P.M.) urine outputs were taken into ice-chilled tubes. After 2 and 4 weeks, 5 rats from each group were killed under ether anesthesia.
Urinalysis and Blood Bioclieiiiistry
Collected urine samples were measured for volume and specific gravity, and then analyzed for total protein (TP), alkaline phosphatase (ALP), glutamic pyruvic transaminase (GPT), lactate dehydrogenase (LDH), y-glutamyl transpeptidase (y-GT), N-acetyl-P-D-glucosaminidase (NAG), glucose, inorganic phosphorus, and electrolyte concentrations ma+, K+, Ca*+, Mg*+, and C1-).
Blood biochemistry assessment was performed for all rats at each sacrifice using the obtained sera. The parameters examined were total protein, albumin, albumin/globulin (NG) ratio, total bilirubin, direct bilirubin, ALP, leucine aminopeptidase, . glutamic oxaloacetic transaminase, GPT, LDH, y-glutamyl transpeptidase, creatine phosphokinase, total cholesterol, triglyceride, phospholipid, blood urea nitrogen, creatinine, uric acid, glucose, inorganic phosphorus, and electrolyte concentrations ma', K+, Ca2+, Mg2+, and C1-). These analyses were performed at the Chunichi Clinic Center, Ohgaki, Japan.
Histopathology arid 5-Bronio-2 '-deoxyiiridine (BrdU) Iiniiiunoliistocheriiistry
All rats were killed 1 hr after an ip injection of BrdU (Sigma Chemical Co., St. Louis, MO) at a dose of 100 mglkg. The final body, kidneys, liver, and spleen weights were measured, and organ-tobody weight ratios were determined. The kidneys, liver, and small intestine were quickly immersed in 10% neutral buffered formalin and, after fixation, embedded in paraffin wax. Sections were cut and processed for routine hematoxylin and eosin staining or immunohistochemical staining of BrdU (5). For each animal the number of labeled nuclei per mm2 of kidney or liver tissue was counted.
Statistical Aiialysis
All data in this study were analyzed by the twosided Student's t-test. Insufficient homogeneity of variance was corrected with respect to the degree of freedom according to Welch. Histopathology data were analyzed by Fisher's exact probability test.
RESULTS
The intake of harman (1,000 ppm and 500 ppm) or norharman (1,000 ppm and 500 ppm), calculated from nominal dietary levels; the mean food consumption; and the mean body weights for each group were 8 1 , 4 1 , 8 1 , and 50 mglkglday, respectively.
No treatment-related deaths were observed. However, statistically significant decrease in body weight gain was evident in rats treated with harman or norharman at 1,000 ppm, but not at 500 ppm, froq we@ 1 to the termination when compared to the control (Fig. 1 ). The water consumption of 1,000 ppm harman and 1,000 ppm norharman groups was extremely high at all times, but this was not the case for the 500 ppm harman and 500 ppm norharman groups (Fig. 1 ). Rats given 1,000 ppm harman or norharman consumed less food than the controls from week 1 to the termination.
Urinalyses performed on days 1, 3, 5 , 7, 14, and 28 revealed consistent, statistically significant increased urine volume and decreased specific gravity in the 1,000 ppm harman and norharman groups, but not in the 500 ppm groups (Fig. 2) . Results for biochemical analyses of urine, corrected for volume to give proportional values (treatedkontrol), revealed marked elevations of NAG, LDH, and sugar in the 1,000 ppm groups for both chemicals, as shown in Fig. 3 . Urinary GGT and ALP levels were clearly decreased after a transitory elevation (early phase of treatment) in the 1,000 ppm harman or norharman groups. However, these changes.were not observed in the 500 ppm harman or norharman groups.
The blood biochemical analyses revealed marked elevation of total cholesterol, triglyceride, phospholipid, blood urea nitrogen, creatinine, uric acid, and magnesium in rats given harman and norharman at 1,000 ppm at weeks'2 and 4 (Table I) . Slight elevations of total cholesterol and phospholipid were observed in rats receiving harman or norharman at 500 ppm. The values for other parameters examined were all essentially within the normal ranges.
The kidneys in rats fed 1,000 ppm, but not 500 ppm, harman or norharman groups demonstrated pale and irregular surfaces. Statistically significant elevation of relative kidney weights was obviously related to gross lesions and growth retardation (Table 11). Relative spleen weight changes were comparable to those of the kidneys and considered to be related to the low body weight of these groups.
On histopathological examination of the kidneys, focal degenerativehecrotic and regenerative lesions of the proximal, distal, and collecting tubules were found in rats given harman or norharman at 1,000 ppm, but not 500 ppm, for 2 weeks. The severity of these lesions was greater at week 4 (Fig. 4) . In the affected tubular lumens, sloughed cells/cellular debris, as well as neutrophils and crystals, were found.
The shape of the crystals were chemical-specific, in the harman case consisting of fine needles forming rounds that were sometimes observed phagocytized by multinucleated cells (Fig. 5) . Crystals found in rats exposed to norharman were characteristically aggregates of long needles (Fig. 6) . These crystals Week 4
Parameters are abbreviated as follows: total cholesterol ( were deposited in the tubules, particularly in the cortex, but also in the medulla and papilla. Although slight proliferation of Bowman's capsule epithelium was apparent, no glomerular alterations were evident. No pelvic transitional cell lesions were observed in any group. No toxic lesions were found in any other tissues examined in the present study. Light microscopic BrdU immunohistochemistry of kidneys revealed that the labeling index (LI) values of affected renal tubular cells in rats fed 1,000 ppm harman (Fig. 7) or norharman were markedly higher than those of the controls (Table 111) . No elevation of LI was evident in the transitional epithelium of the pelvis or in the hepatocytes of the liver (data not shown).
DISCUSSION
Renal tubular cell toxic degenerativehecrotic and regenerative changes found in rats exposed to harman or norharman at 1,000 ppm, but not 500 ppm, were consistent with those reported previously (3, 6, 14). Although the renal tubular epithelium was severely affected by harman or norharman treatment, glomerular damage was minimal. This was clearly reflected in the urinalysis data, where marked elevation of urine volume, lysosomal enzymes (NAG and LDH), and sugar excretions, and decrease of brush border enzymes (ALP and GGT), but no increase in urinary protein excretion, were found. Blood biochemistry data obtained also indicated the occurrence of severe nephrosis. The current study therefore suggests that the increased water intake and urine volume may be caused primarily by prevention of reabsorption of water by the distal and collecting tubular epithelial cells. These adverse effects are common to many nephrotoxic agents (9, 18, 26) .
Deposition of crystals in the lumina of the renal tubules was the most striking finding in rats given harman or norharman. This was clearly dose de- pendent, only being found with the 1,000 ppm treatment. It is well established that there are 3 types of drug-treatment-associated crystals (oxalates, urates, and those composed of the given drug themselves) causing nephropathy (9, 18, 26) . Oxalate and urate crystals, which are found in normal urine and show a high pH dependency, can be identified by their microscopic structure. Oxalate or urate nephropathy could be ruled out in the harman and norharman cases, because additional examination of urine sediments revealed marked crystals, which were comparable to those observed in the renal tubules. In the present case, therefore, the chemicals themselves or poorly soluble metabolites are likely to have precipitated in the lumina of the affected renal tubules.
Increased rates of DNA synthesis in renal tubular cells demonstrated during the experimental period were presumably directly related to renal toxic le- sions. Similarly, sodium barbital and lead acetate, established renal toxins and, respectively, a tumor promoter and carcinogen, were reported to increase levels of DNA synthesis and renal tubular cell hyperplasia after 52 or 26 weeks of treatment, respectively (1, 2, 4). Lead acetate and the strong kidney carcinogen dimethylnitrosamine also cause increased DNA synthesis after a single injection (2, 7). It has been reported that quantitative analysis of replicative DNA synthesis after a single injection might be a useful approach to detection of potential renal carcinogens in a short-term period (12) . Whether this is indeed associated with promotion of kidney carcinogenesis, as shown for a variety of other nephrotoxic agents (8, 20) , requires further investigation.
In conclusion, the present investigation clearly demonstrated that harman and norharman both ex- 7. -A large number of BrdU-positive renal tubular cell nuclei, which are quite rare in normal renal tubular epithelium, are evident in the semi-serial section to preparation (Fig. 4) . Immunohistochemical BrdU staining, x 100. ert renal tubular toxicity with a high threshold level. The actual renal toxic hazard of these agents to humans may therefore be negligible, because our own intake levels are estimated to be very low (19, (21) (22) (23) . At present, from the limited evidence available, it is impossible to assess the toxic potential of both chemicals for man, and further investigations (including studies focussed on metabolism and tissue distribution) are needed.
